Розацеа. Часть 1. Рубрика “Медикрис доказательный”.
В этом видео врач-дерматолог клиники “Медикрис” Варвара Забродина подробно рассказывает о болезни розацеа. Почему появляется, ее подтипах, а также затрагивает методы лечения.
“Медикрис” - это команда высококвалифицированных врачей-дерматологов, косметологов, трихологов, хирургов и флебологов.
ОТЗЫВЫ: yandex.ru/maps/org/medicris/1...
ТЕЛЕГРАММ t.me/medicris
ИНСТАГРАММ / medicris_ru
CАЙТ www.medicris.ru
Наши методы лечения и оказания помощи пациентам основаны на научных исследованиях и доказательной медицине.
Ссылки на используемую научную литературу:
1) Odom R, Dahl M, Dover J, et al. Standard management options for rosacea, part 2: options according to subtype. Cutis 2009; 84:97.
2) Wilkin J. A role for vascular pathogenic mechanisms in rosacea: implications for patient care. Cutis 2008; 82:100.
3) Schaller M, Almeida LMC, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol 2020; 182:1269.
4) Aksoy B, Altaykan-Hapa A, Egemen D, et al. The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. Br J Dermatol 2010; 163:719.
5) Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51:327.
6) www.rosacea.org/rr/2002/summer/article_3.php (Accessed on December 28, 2010).
7) Guarrera M, Parodi A, Cipriani C, et al. Flushing in rosacea: a possible mechanism. Arch Dermatol Res 1982; 272:311.
8) Wilkin JK. Effect of subdepressor clonidine on flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions. Arch Dermatol 1983; 119:211.
9) Hsu CC, Lee JY. Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective β-adrenergic blocker. J Am Acad Dermatol 2012; 67:491.
10) Nichols K, Desai N, Lebwohl MG. Effective sunscreen ingredients and cutaneous irritation in patients with rosacea. Cutis 1998; 61:344.
11) www.accessdata.fda.gov/drugsat... (Accessed on August 27, 2013).
12) van Zuuren EJ, Fedorowicz Z, Carter B, et al. Interventions for rosacea. Cochrane Database Syst Rev 2015; :CD003262.
13) Tanzi EL, Weinberg JM. The ocular manifestations of rosacea. Cutis 2001; 68:112.
14) Stone DU, Chodosh J. Ocular rosacea: an update on pathogenesis and therapy. Curr Opin Ophthalmol 2004; 15:499.
15) Bakar O, Demircay Z, Toker E, Cakir S. Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin. J Eur Acad Dermatol Venereol 2009; 23:544.
16) Apikian M, Goodman GJ, Roberts S. Management of mild to moderate rhinophyma with a 1,450-nm diode laser: report of five patients. Dermatol Surg 2007; 33:847.
17) Sadick H, Goepel B, Bersch C, et al. Rhinophyma: diagnosis and treatment options for a disfiguring tumor of the nose. Ann Plast Surg 2008; 61:114.
19) Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 46:584.
20) Helm KF, Menz J, Gibson LE, Dicken CH. A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol 1991; 25:1038.
21) Sánchez JL, Berlingeri-Ramos AC, Dueño DV. Granulomatous rosacea. Am J Dermatopathol 2008; 30:6.
22) Li S, Chen ML, Drucker AM, et al. Association of Caffeine Intake and Caffeinated Coffee Consumption With Risk of Incident Rosacea in Women. JAMA Dermatol 2018; 154:1394.
Негізгі бет Все о Розацеа (Rosacea) - Доказательная медицина
Пікірлер: 28